Sign up to save your podcasts
Or
Share Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2
In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan.
Show references:
https://doi.org/10.1016/s1474-4422(21)00159-9
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract
View all episodes
By American Academy of Neurology
4.8
129129 ratings
In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan.
Show references:
https://doi.org/10.1016/s1474-4422(21)00159-9
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract
More shows like Neurology Minute
View all
JAMA Editors' Summary
130 Listeners
Neurology® Podcast
289 Listeners
NEJM This Week
325 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
492 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
87 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
185 Listeners
Navigating Neuropsychology
340 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
77 Listeners